InvestorsHub Logo
Followers 27
Posts 1152
Boards Moderated 0
Alias Born 11/05/2020

Re: Mr.Green post# 104032

Sunday, 02/13/2022 10:53:06 AM

Sunday, February 13, 2022 10:53:06 AM

Post# of 118423

The Canary 8K was the death nail to RGBP, it is a newly created company with no history that would acquire shares of RGBP at 1 cent in a partnership of sorts.



There is nothing strange about what transpired between Lander's new formed company (Canary) and Cornell University. In fact, the acting members are part of Cornell.

Intellectual property was created. A deal was made between the university to "house" property in a new company between the two parties.

This can be done for a few reasons but one reason in particular is to have a separate agreement between any other parties that will/would get involved.

The company holding the IP's history is irrelevant in the scheme of the larger business ecosystem. The company (Canary) isn't looking to build the company.

As far as I can tell, all indications are this is a scam to funnel 50 million dollars over from RGBP to a newly formed Canary company with no proof of work.



Again, your missing some pieces (see above).

There is no "scam" from RGBP. There can't be. RGBP has nothing more to do with Canary than to find securing. That's it. If that happens, then the the relationship gets closer.

"Proof of work" has no bearing on a newly formed company in this situation. Canary is nothing more than a "house" to hold a particular "asset."

The last 2 news releases didn't even hold the .0008 gap ups.



Why should it? I have mentioned it here before but looking over some parts of Market Microstructure (particularly price discovery) might answer some things.

Using covid as an example of bringing recognition to MRNA technology is another bad example



It's not the same; mRNA is a versatile platform.

The Covid vaccine is but one variation of the larger platform. The biochemistry isn't the same between the Covid vaccine and cancer vaccines.